Evaluation of the Impact of an Expert Opinion During the Management of Patients With Severe Bleeding on Oral Anticoagulants.

Launched by UNIVERSITY HOSPITAL, CLERMONT-FERRAND · Jun 23, 2023

Keywords

ClinConnect Summary

This clinical trial is studying whether getting advice from an expert can improve the care of patients who experience severe bleeding while taking blood-thinning medications known as oral anticoagulants. Researchers want to find out if having an expert involved in the decision-making during treatment is better than following standard treatment practices. The trial will involve emergency departments that will be divided into two groups: one will follow the usual management, while the other will include expert guidance.

To participate in this trial, patients need to be between the ages of 65 and 74, admitted to the emergency department for suspected major bleeding, and able to give their consent or have a representative do so in emergencies. Participants will be monitored closely during their hospital stay and will have follow-up calls after three months to check for any complications, such as new bleeding or blood clots. This study aims to find out the best way to manage patients with severe bleeding, which could help improve their treatment outcomes.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Major patient treated with oral anticoagulants, admitted in an emergency department
• • For suspected major bleeding defined according to the criteria of the International Society of Thrombosis and Haemostasis
• • Able to give informed consent to participate in research or, in the event of an emergency, to take charge of a reference person
• • Affiliated to a Social Security scheme.
• Exclusion Criteria:
• • Pregnant or breastfeeding women
• • Patient under guardianship, curatorship or safeguard of justice
• • Administration within the last 24 hours of parenteral anticoagulant.
• • Refusal to participate